Mettler-Toledo International (MTD) is a publicly traded Healthcare sector company. As of May 21, 2026, MTD trades at $1,084.86 with a market cap of $21.72B and a P/E ratio of 25.35. MTD moved +2.96% today. Year to date, MTD is -25.16%; over the trailing twelve months it is -8.71%. Its 52-week range spans $946.69 to $1,525.17. Analyst consensus is buy with an average price target of $1,349.69. Rallies surfaces MTD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded MTD stock?
Recent politician trading activity in MTD includes disclosures from Rob Bresnahan, Julie Johnson, and Tommy Tuberville. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
MTD Key Metrics
Key financial metrics for MTD
Metric
Value
Price
$1,084.86
Market Cap
$21.72B
P/E Ratio
25.35
EPS
$42.70
Dividend Yield
0.00%
52-Week High
$1,525.17
52-Week Low
$946.69
Volume
4
Avg Volume
0
Revenue (TTM)
$4.09B
Net Income
$875.06M
Gross Margin
59.19%
Congressional Trades in MTD
Rob Bresnahan purchase MTD on May 15, 2025 (amount: $15.00K).
Julie Johnson sale MTD on Apr 1, 2025 (amount: $15.00K) for Joint.
Tommy Tuberville sale (full) MTD on Apr 3, 2023 (amount: $15.00K) for Joint.
Recent politician trading activity in MTD includes disclosures from Rob Bresnahan, Julie Johnson, and Tommy Tuberville. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in MTD?
Yes. Rallies tracks politician and congressional stock disclosures for MTD, including reported purchases, sales, dates, owners, and trade amounts when available.
Is MTD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MTD. It does not provide personalized investment advice.
